Table 7.
VK, mg/kg | SEc | Cad, mmol/L | CTe, pg/mL | PTHf, pg/mL | cOCg, ng/mL | ucOCh, ng/mL | cOC/(cOC + ucOC), % | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Week 42 | Week 44 | Week 42 | Week 44 | Week 42 | Week 44 | Week 42 | Week 44 | Week 42 | Week 44 | Week 42 | Week 44 | ||
0 | – | 5.83 | 3.47b | 321.53 | 231.04 | 102.19 | 98.26 | 2.38 | 2.07 | 2.10 | 2.43 | 57.92 | 44.33 |
0 | + | 5.40a | 330.98 | 99.39 | 1.87 | 2.46 | 43.90 | ||||||
2 | – | 5.03 | 4.66ab | 270.89 | 262.15 | 67.43 | 92.20 | 2.32 | 2.45 | 1.54 | 1.45 | 59.75 | 63.70 |
2 | + | 4.57ab | 301.62 | 81.93 | 2.76 | 1.39 | 67.64 | ||||||
SEMi | 0.973 | 0.406 | 29.193 | 25.980 | 15.255 | 8.219 | 0.301 | 0.100 | 0.400 | 0.285 | 0.731 | 2.539 | |
0 | – | 4.37 | – | 246.60b | – | 98.64 | – | 1.99b | – | 2.44a | – | 44.16b | |
2 | – | 4.62 | – | 314.20a | – | 88.78 | – | 2.52a | – | 1.43b | – | 64.69a | |
SEMi | – | 0.287 | – | 17.770 | – | 5.897 | – | 0.073 | – | 0.179 | – | 2.273 | |
– | – | 4.06b | – | 281.01 | – | 95.23 | – | 2.67 | – | 2.01 | – | 54.02 | |
+ | – | 4.98a | – | 284.71 | – | 90.66 | – | 2.76 | – | 1.92 | – | 51.81 | |
SEMi | – | 0.287 | – | 17.770 | – | 5.811 | – | 0.071 | – | 0.178 | – | 2.244 | |
VK | 0.622 | 0.661 | 0.345 | 0.022 | 0.248 | 0.20 | 0.898 | < 0.001 | 0.424 | 0.005 | 0.220 | 0.001 | |
P-values8 | SE | – | 0.032 | – | 0.973 | – | 0.60 | – | 0.662 | – | 0.959 | – | 0.611 |
VK × SE | – | 0.019 | – | 0.260 | – | 0.513 | – | 0.051 | – | 0.861 | – | 0.530 |
a, bMeans within a column with no common superscripts differ (P < 0.05)
cSE Salmonella Enteritidis; −, without SE challenge; +, with SE challenge
dCa Calcium
eCT calcitonin
fPTH Parathyroid hormone
gcOC Carboxylated osteocalcin
hucOC Undercarboxylated osteocalcin
iSEM Pooled standard error of the mean
8P-values for main effect of VK, the main effect of SE challenge, and the interaction between the VK treatments and SE challenge